Insights On Downstream Manufacturing

  1. Inside The Development Of An AAV8 Production Platform 4/24/2025

    Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.

  2. High-Sensitivity Residual E. coli DNA Testing Supporting Biologics, CGT Development 4/23/2025

    Advancements in high-sensitivity residual DNA testing enhance the precision of plasmid DNA purity analysis, ensuring compliance with regulatory standards critical for manufacturing processes.

  3. Leveraging Efficiency From CLD To Clinical Manufacturing Of mAbs 4/23/2025

    Discover how our efficient strategies can propel your mAb from discovery to clinical manufacturing in as little as 18 months.

  4. Process Analytical Technology In The ADC Bioconjugation Process 4/23/2025

    Integrating Process Analytical Technology into validated GMP processes is complex and costly, which requires thorough validation of equipment and cleaning methods. Explore more about PAT's role in ADC production.

  5. Redefine Your Oligonucleotide Manufacturing 4/22/2025

    Streamline oligo production and scale confidently. Explore high-performing, purpose-built automated equipment designed to ensure safety, efficiency, and purity, from synthesis through concentration.

  6. Optimized Transient Production: Faster Preclinical Studies With Enhanced QC 4/21/2025

    Accelerate your path from discovery to clinic by leveraging high-quality plasmid DNA, optimized expression systems, and early developability assessments to streamline transient protein production.

  7. Sterile Gas Filtration And Optimization In Bioprocessing 4/17/2025

    Unlock insights into sterile gas filtration challenges in bioprocessing. Watch this on-demand session to learn optimization strategies for critical applications and improved filter performance.

  8. Increasing Biopharmaceutical Manufacturing Downstream Process Efficiencies 4/16/2025

    Downstream processing can account for up to 80% of biopharmaceutical production costs. Optimizing this stage is crucial for resource management, product quality, and overall yield.

  9. 9 Essential Oligosynthesis Component Needs 4/16/2025

    Meeting the growing need for oligonucleotides means having the right tools. Learn about the nine indispensable components, such as synthesis columns and C&D systems, for your facility.

  10. Shedding Light On Oligonucleotide Manufacturing 4/16/2025

    While oligonucleotide therapeutics show immense promise by targeting genetic codes, scaling up manufacturing presents unique challenges requiring innovative equipment solutions to meet growing demand.